US FDA And The Lonely Return To The Office

Employees are beginning to work in the office again, but are not finding many colleagues while at the agency’s White Oak headquarters.

Hybrid work
Some in industry are adopting hybrid work models to allow for in-person collaboration, while still providing a flexible environment. • Source: Shutterstock

Like much of the world, the US Food and Drug Administration is beginning to let staff return to the office, but may be having trouble maximizing its potential benefits, such as interacting with colleagues face-to-face.

John Scott, director of the Division of Biostatistics in the Center for Biologics Evaluation and Research’s Office of Biostatistics and...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet